Video Experimental Relacionado
Updated: Jul 17, 2026
09:18
Spheroid Assay to Measure TGF-β-induced Invasion
Published on: November 16, 2011
MTA3, una subunidad del complejo Mi-2/NuRD, regula una vía de crecimiento invasivo en el cáncer de mama
Naoyuki Fujita1, David L Jaye, Masahiro Kajita
1Emory University School of Medicine, Department of Pathology, Whitehead Biomedical Research Building, Room 142, 615 Michael Street, Atlanta, GA 30322, USA.
Cell
|April 23, 2003
Resumen
El receptor de estrógeno y el MTA3 regulan el crecimiento y la diferenciación del cáncer de mama. Su ausencia hace que Snail aumente, promoviendo el crecimiento invasivo mediante la reducción de E-cadherin.
Área de la Ciencia:
- Biología Molecular Biología Molecular
- Biología del cáncer Biología del cáncer.
- Biología celular Biología celular.
Sus antecedentes:
- El receptor de estrógeno (ER) es vital para el desarrollo de la glándula mamaria y un objetivo clave en el cáncer de mama.
- ER influye en la proliferación celular y la diferenciación a través de la expresión génica.
- La comprensión de los efectores aguas abajo de ER es crucial para la terapia del cáncer de mama.
Objetivo del estudio:
- Identificar nuevos reguladores dependientes del estrógeno en las células epiteliales mamarias.
- Para aclarar el papel de MTA3 en las vías mediadas por ER.
- Establecer un vínculo mecánico entre el estado de ER y la invasividad del cáncer de mama.
Principales métodos:
- Investigó el papel del MTA3 humano en el complejo corepresor transcripcional Mi-2/NuRD.
- Se analizó el impacto del receptor de estrógeno y la ausencia de MTA3 en la expresión del caracol.
- Se evaluó el efecto de la expresión aberrante de caracol en la E-caderina y la arquitectura epitelial.
Principales resultados:
- MTA3 identificado como un componente dependiente del estrógeno del complejo Mi-2/NuRD en las células mamarias.
- La ausencia de ER o MTA3 conduce a una expresión aberrante del represivo de Snail.
- La expresión de caracol aberrante resulta en una disminución de la E-cadherina, promoviendo el crecimiento invasivo.
Conclusiones:
- MTA3 es un mediador clave en una vía dependiente del estrógeno que controla el crecimiento y la diferenciación de las células mamarias.
- La interrupción de la vía del receptor de estrógeno y la MTA3 está vinculada a los fenotipos invasivos del cáncer de mama.
- Este estudio establece una conexión mecánica entre el estado de ER y el crecimiento invasivo en el cáncer de mama.
Videos de Conceptos Relacionados
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...